Clinical trials
Phase 3 Hypocalcemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2013 | 4 |
| 2018 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Columbia University | 1 |
| Hôpital NOVO | 1 |
| Instituto Palacios | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Saint Petersburg State University, Russia | 1 |
| University Hospital, Brest | 1 |
| University of California, Irvine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypocalcemia | 12 |
| Hyperparathyroidism, Secondary | 5 |
| Hypoparathyroidism | 4 |
| Renal Insufficiency, Chronic | 4 |
| Hypercalciuria | 2 |
| Calcium Metabolism Disorders | 1 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Hemorrhage | 1 |
| Metabolic Diseases | 1 |
| Muscular Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.